Cue Biopharma, Inc. (CUE): Long-Term Debt

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Long-Term Debt is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$4.00M
As of 2023-12-31
$8.00M2022-12-31: $8.00M2023-12-31: $4.00M$4.00M
2022-12-31 Long-Term Debt (USD) 2023-12-31
Period endedLong-Term DebtChange YoYSource filing
2023-12-31$4.00M-50.0%2024-03-28, Balance as of period end
2022-12-31$8.00Mn/a2023-03-21, Balance as of period end